These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1726058)

  • 21. Thin-needle aspiration biopsy of the prostate.
    Koss LG; Woyke S; Schreiber K; Kohlberg W; Freed SZ
    Urol Clin North Am; 1984 May; 11(2):237-51. PubMed ID: 6203204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The accuracy of transrectal aspiration biopsy in routine diagnosis of prostatic carcinoma].
    Maier U; Holub G; Krepler R
    Wien Klin Wochenschr; 1980 Nov; 92(22):803-5. PubMed ID: 7467360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Andersson L; Hagmar B; Ljung BM; Skoog L
    Scand J Urol Nephrol Suppl; 1994; 162():43-9; discussion 115-27. PubMed ID: 7817160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
    Epstein JI; Herawi M
    J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transretcat aspiration biopsy in the diagnosis of prostatic cancer (author's transl)].
    Droese M; Soost HJ; Voeth C
    Urologe A; 1976 Jan; 15(1):13-7. PubMed ID: 1258227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of fine needle aspiration as a screening test for occult prostatic carcinoma.
    Suhrland MJ; Deitch D; Schreiber K; Freed S; Koss LG
    Acta Cytol; 1988; 32(4):495-8. PubMed ID: 3400389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.
    Kaić G; Tomasović-Loncarić C
    Diagn Cytopathol; 2009 Nov; 37(11):803-8. PubMed ID: 19459159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Importance of impulse cytophotometry in the diagnosis and prognosis of prostate cancer].
    Zimmermann A; Truss F; Blech M; Schröter W; Barth M
    Urologe A; 1983 May; 22(3):151-6. PubMed ID: 6192580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic and prognostic significance of cytological malignancy grading of prostatic carcinoma].
    Faul P
    Urologe A; 1983 May; 22(3):127-33. PubMed ID: 6683896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Aspiration cytological diagnosis in carcinoma of the prostate].
    Serck-Hansen A; Waaler G
    Tidsskr Nor Laegeforen; 1974 Apr; 94(12):773-6. PubMed ID: 4133818
    [No Abstract]   [Full Text] [Related]  

  • 33. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transrectal thin-needle aspiration biopsy of prostate: four years' experience.
    Zattoni F; Pagano F; Rebuffi A; Costantin G
    Urology; 1983 Jul; 22(1):69-72. PubMed ID: 6191423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benign mimics of prostatic adenocarcinoma on needle biopsy.
    Gaudin PB; Reuter VE
    Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
    Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Systematic bilateral aspiration biopsy in the screening of prostatic cancer].
    Voisin E; Piaton E; Duco F; Morettini C; Brocard MC; Toscan Du Plantier N
    J Urol (Paris); 1990; 96(6):343-7. PubMed ID: 2280089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
    Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Needle biopsy in diagnosis of prostatic cancer.
    KAUFMAN JJ; ROSENTHAL M; GOODWIN WE
    Calif Med; 1954 Nov; 81(5):308-13. PubMed ID: 13209358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of telomerase activity in prostate needle-biopsy samples].
    Wang X; Zhang Y; Ding Q; Ye L; Zhai L; Jia W
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):762-4. PubMed ID: 11829949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.